# VENTAK(R) P2 SYSTEM (Boston Scientific)

Product · id `cardio:fdaprod-p930035` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [openFDA record P930035](<https://api.fda.gov/device/pma.json?search=pma_number:P930035>), retrieved 8 November 2026. No person wrote or checked this page.

Browse, organ or system: Heart  
Browse, condition area: Heart rhythm problems  

## In plain language

A premarket approval (PMA) application in FDA's device records. FDA's decision code for the original application reads approved.

## Technical summary

PMA P930035. Decision 1995-03-10. Product code LWS. Device class III.

## The registry's words

- PMA number: P930035
- Trade name: VENTAK(R) P2 SYSTEM
- Generic name: Implantable cardioverter defibrillator (non-CRT)
- Applicant: Boston Scientific
- Product code: LWS
- Advisory committee: Cardiovascular

## Claims, with the population each applies to

## Context: FDA record read by the openFDA feed

Recipient: Recipient not specified; Population: Not stated in the openFDA record; Care setting: Not stated in the openFDA record; Geography: United States (a decision by the US Food and Drug Administration); Life stage: Not stated in the openFDA record; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (regulatory decision)

### FDA records an approval of P930035 on 1995-03-10.

- Category: Regulatory
- Evidence stage: Evidence stage not applicable
- Certainty: Certainty not assessed
- Applies to: Recipient: Recipient not specified; Population: Not stated in the openFDA record; Care setting: Not stated in the openFDA record; Geography: United States (a decision by the US Food and Drug Administration); Life stage: Not stated in the openFDA record; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (regulatory decision)
- Limitations: Assembled by a program from openFDA; the approved or cleared uses are in FDA's own decision documents, which this record does not read. openFDA says its data is unvalidated and not for medical decisions.
- Last checked: Not recorded
- Sources:
  1. Supports: FDA premarket approval record P930035 (openFDA record) (Regulator) <https://api.fda.gov/device/pma.json?search=pma_number:P930035>
     Locator: decision\_date. Retrieved 2026-11-08T02:46:30Z. Source state: Current. Version fingerprint: 61017db8084656319123bedebcc2155b1f7465ddd084f7630be6e86c9832e75b.
     How it applies: The decision date as the record writes it.
  2. Supports: FDA premarket approval record P930035 (openFDA record) (Regulator) <https://api.fda.gov/device/pma.json?search=pma_number:P930035>
     Locator: pma\_number. Retrieved 2026-11-08T02:46:30Z. Source state: Current. Version fingerprint: 61017db8084656319123bedebcc2155b1f7465ddd084f7630be6e86c9832e75b.
     How it applies: The registry number of the record.
  3. Supports: FDA premarket approval record P930035 (openFDA record) (Regulator) <https://api.fda.gov/device/pma.json?search=pma_number:P930035>
     Locator: decision\_code. Retrieved 2026-11-08T02:46:30Z. Source state: Current. Version fingerprint: 61017db8084656319123bedebcc2155b1f7465ddd084f7630be6e86c9832e75b.
     How it applies: The decision status as the record writes it.

## Guidance, authorization and access

### Regulatory decision `cardio:fdadec-p930035-approval`

- Product: VENTAK(R) P2 SYSTEM (Boston Scientific) (`cardio:fdaprod-p930035`)
- Authority: U.S. Food and Drug Administration (`core:fda`)
- Decision: Approval, 1995-03-10
- Product version: Original application
- Pathway: PMA
- Submission: P930035
- Product code: LWS
- Device class: III
- Indication: Not stated in the openFDA record
- Jurisdictions: United States
- Applies to: Recipient: Recipient not specified; Population: Not stated in the openFDA record; Care setting: Not stated in the openFDA record; Geography: United States (a decision by the US Food and Drug Administration); Life stage: Not stated in the openFDA record; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (regulatory decision)
- Basis: claim `cardio:fdaclaim-p930035-approval`

## Connected pages

- Registry product code files this product under this technology: Implantable cardioverter-defibrillator (ICD) (`cardio:implantable-cardioverter-defibrillator`)

## Provenance

Content hash: af4cb99842cc3ffe9c5838faa63d24d5adcbb0e10dd0d3310faf4b74fa8cf291
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
